Latest Information Update: 05 Dec 2007
At a glance
- Originator Organon
- Class Antiprogestogens; Estrenes
- Mechanism of Action Progesterone receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Contraception
Most Recent Events
- 19 May 2003 Phase-II clinical trials in Contraception in Netherlands (unspecified route)